Page last updated: 2024-09-05

sorafenib and whi p180

sorafenib has been researched along with whi p180 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(whi p180)
Trials
(whi p180)
Recent Studies (post-2010) (whi p180)
6,5207305,2511508

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)whi p180 (IC50)
Chain A, CYCLIN-DEPENDENT KINASE 2Homo sapiens (human)1
Chain A, P38 KINASEHomo sapiens (human)1
Proto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)0.1922
Fibroblast growth factor receptor 1Homo sapiens (human)0.125
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.1625
Cyclin-dependent kinase 2Homo sapiens (human)1
Phosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)0.002
Ephrin type-B receptor 2Homo sapiens (human)1.2
Kinesin-1 heavy chainHomo sapiens (human)0.38
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.1787
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.05

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cao, LQ; Liu, H; Lv, BB; Shi, L; Wang, R; Wang, XY; Xu, YG; Xue, JY; You, YY1

Other Studies

1 other study(ies) available for sorafenib and whi p180

ArticleYear
Discovery of novel VEGFR-2 inhibitors embedding 6,7-dimethoxyquinazoline and diarylamide fragments.
    Bioorganic & medicinal chemistry letters, 2021, 03-15, Volume: 36

    Topics: Amides; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; MCF-7 Cells; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2

2021